No Established Role for Vitamin B1 in Treating Erectile Dysfunction
Vitamin B1 (thiamine) has no established role in the treatment of erectile dysfunction based on current clinical practice guidelines. The standard of care for ED management focuses on PDE-5 inhibitors as first-line therapy, with no mention of thiamine supplementation in any major guideline 1, 2, 3.
Evidence-Based Treatment Approach
First-Line Therapy
The American College of Physicians and American Urological Association both provide strong recommendations that clinicians should initiate therapy with a PDE-5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil) in men seeking ED treatment unless contraindicated 1, 2. This recommendation is based on high-quality evidence from studies involving nearly 250,000 men.
Why Thiamine Is Not Recommended
The clinical practice guidelines comprehensively address pharmacologic and hormonal management of ED but make no mention of vitamin B1 supplementation 1. The FDA-approved indications for thiamine are limited to treating thiamine deficiency states (beriberi, Wernicke's encephalopathy, cardiovascular disease due to thiamine deficiency) - not erectile dysfunction 4.
Examining the Limited Evidence
Observational Data
One recent observational study from 2025 found an association between higher dietary thiamine intake and lower ED incidence in U.S. men, with an adjusted OR of 0.782 for those consuming >1.3 μg daily 5. However, this is:
- Cross-sectional data showing correlation, not causation
- Based on self-reported dietary intake and ED status
- Not a clinical trial testing thiamine supplementation
- Insufficient to change clinical practice
Animal Studies
A 1978 rat study showed that thiamine-deficient rats developed persistent erection, which resolved with thiamine replacement 6. This finding is:
- Not applicable to human ED treatment
- Describes a pathological state (priapism) in severe deficiency, not therapeutic benefit
- Decades old with no follow-up human research
Clinical Pitfalls to Avoid
Do not delay evidence-based treatment by attempting thiamine supplementation. Men presenting with ED should receive:
- Immediate PDE-5 inhibitor therapy unless contraindicated (particularly with nitrate use) 1, 2
- Proper dosing instructions including need for sexual stimulation and multiple trials 2
- Dose titration to optimize efficacy while minimizing adverse effects 2
When to Consider Nutritional Assessment
Thiamine supplementation is only indicated when:
- Documented thiamine deficiency exists (measure RBC or whole blood thiamine diphosphate) 7
- Patient has risk factors: chronic alcohol use, malabsorption, prolonged diuretic therapy, or inadequate nutrition 7, 4
- Clinical signs of deficiency: cardiomyopathy, neuropathy, encephalopathy 7, 4
In these cases, treat the deficiency itself (100-300 mg IV for acute deficiency, 10-100 mg oral for maintenance) 7, 4, but do not expect ED improvement - proceed with standard ED therapy.
Hormonal Considerations
If hormonal evaluation is pursued, focus on testosterone deficiency, not vitamin supplementation. The ACP guideline notes insufficient evidence for routine hormonal testing, but when testosterone deficiency is documented, combination therapy with PDE-5 inhibitors may be more effective than PDE-5 inhibitors alone 2, 1, 3.
Alternative Evidence-Based Adjuncts
If seeking adjunctive therapies beyond PDE-5 inhibitors, consider options with actual supporting evidence:
- Antioxidant supplementation showed a mean IIEF-EF improvement of 5.5 points in a 2025 meta-analysis, particularly in men with severe ED 8
- Vacuum erection devices with 90% initial efficacy 2, 3
- Intracavernous injection therapy for PDE-5 inhibitor nonresponders 3
The bottom line: Prescribe a PDE-5 inhibitor, not thiamine, for erectile dysfunction. Only supplement thiamine if documented deficiency exists, and continue standard ED therapy regardless.